As expected, the AUC of the plasma SVM model based on five putative metabolites in diagnosing the early-stage ovarian carcinoma reached 0.847and 0.988 in discovery and validation sets respectively, which were higher than 0.733 and 0.893 of CA125 alone (Figure 5a,b). This evidence concerns the gene MUC16 and ovarian carcinoma.